| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $47,156,460 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM140983 | Trauma and Shock-Induced Microvascular Dysregulation and Coagulopathy | 000 | 4 | NIH | 1/16/2025 | $543,525 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U24HL175772 | A consortium facilitation, coordination, and data management center for the HVP | 000 | 1 | NIH | 1/15/2025 | $3,000,337 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI161839 | Broad spectrum Shigella subunit vaccine based on conserved proteins | 000 | 5 | NIH | 1/16/2025 | $528,481 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI175439 | Anti-flavivirus B cell response analysis to aid vaccine design | 000 | 3 | NIH | 1/6/2025 | $748,034 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 000 | 3 | NIH | 12/20/2024 | $503,935 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31DA062453 | The Impact of Perinatal Fentanyl on Dopamine Neuron Circuitry and Behavior | 001 | 1 | NIH | 12/12/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA270591 | Dual inhibition of PARP and STAT3 as a novel therapeutic approach for triple-negative breast cancer | 000 | 2 | NIH | 1/14/2025 | $163,063 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL172364 | Modulating the resolution of angiogenesis and normalization of the vasculature for therapeutic benefit | 000 | 1 | NIH | 1/13/2025 | $549,665 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG079854 | Methods to Test Biomarkers of Aging as Shared Determinants of Alzheimers Disease and Related Dementias and Physical Disability | 000 | 3 | NIH | 11/26/2024 | $653,435 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31DA062453 | The Impact of Perinatal Fentanyl on Dopamine Neuron Circuitry and Behavior | 002 | 1 | NIH | 12/12/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK130238 | Pharmacogenetics of the Response to a GLP1R Agonist | 000 | 4 | NIH | 11/25/2024 | $604,825 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DC013817 | Cell Type Specific Transcriptional Cascades in Inner Ear Development | 000 | 10 | NIH | 11/26/2024 | $490,911 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD007982 | Racial and Ethnic Minority Acceleration for Health Equity Consortium U01 | 001 | 2 | FDA | 11/26/2024 | $100,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01AI168587 | Systems Vaccinology Approaches to Define and Predict Immunity in Response to Nontyphoidal Salmonella Conjugate Vaccines | 000 | 4 | NIH | 1/14/2025 | $129,222 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM144147 | Photonics-based Fluorescence Imaging for Research, Diagnostics, and Pathology | 001 | 4 | NIH | 1/27/2025 | $347,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA298839 | Tumor-associated pDC (TApDC) in liver cancer with HIV infection | 000 | 1 | NIH | 12/5/2024 | $634,061 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR077563 | Molecular Determinants of Pigmentation (MDoP) | 000 | 4 | NIH | 12/5/2024 | $435,440 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA279108 | The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer | 000 | 2 | NIH | 1/27/2025 | $567,729 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH131566 | Reward, Salience and Value Processing in Youths at Risk for Psychosis: The RSVP Study | 000 | 2 | NIH | 1/28/2025 | $686,479 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR083363 | Lipid metabolism in the growth plate | 000 | 2 | NIH | 12/5/2024 | $482,145 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R00DK131018 | Unravelling the Role of Epigenetics and Cytokines in Type 2 Diabetes among African-ancestry Populations | 000 | 3 | NIH | 1/21/2025 | $248,915 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R13HS029601 | ASTARISQ: Addressing systemic and STructurAl Racism to Improve Safety, Quality, and trustworthiness in health delivery systems | 000 | 2 | AHRQ | 2/25/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01ES033301 | Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney | 000 | 4 | NIH | 3/6/2025 | $363,710 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032692 | Novel tunable metformin-releasing injectable scaffolds to enhance dental pulp stem cell-based craniofacial bone regeneration | 000 | 2 | NIH | 3/26/2025 | $316,339 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162120 | Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis | 000 | 4 | NIH | 2/19/2025 | $568,382 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI183599 | Genomic surveillance for artemisinin resistance in Africa: moving beyond a candidate gene approach | 001 | 1 | NIH | 2/19/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 3 | NIH | 3/16/2025 | $245,116 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 3 | NIH | 3/16/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33AG076858 | Cell-type and organelle-specific multi-omics platform for the study of brain aging | 000 | 4 | NIH | 3/12/2025 | $600,629 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DA041117 | 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | 000 | 11 | NIH | 3/13/2025 | $1,677,585 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR077562 | Taming IL-33 to Control Inflammation and Fibrosis | 000 | 5 | NIH | 3/24/2025 | $305,910 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI190438 | Development of Oral Immunotherapy against Clostridioides difficile Transmission | 000 | 1 | NIH | 3/14/2025 | $511,553 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R34AR084146 | A Planning Grant for a Multi-Center Randomized Controlled Trial Comparing Resection and Endoprosthetic Reconstruction vs. Internal Fixation for Metastatic Bone Disease of the Proximal Femur | 000 | 2 | NIH | 3/13/2025 | $136,171 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW012213 | Scaling Up Research Ethics and Research Integrity (SURER) Project | 000 | 4 | NIH | 3/12/2025 | $95,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW012213 | Scaling Up Research Ethics and Research Integrity (SURER) Project | 000 | 4 | NIH | 3/12/2025 | $150,742 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011811 | Eastern Nigeria Research Ethics Training (ENRICH) Program | 001 | 5 | NIH | 3/12/2025 | $41,272 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011811 | Eastern Nigeria Research Ethics Training (ENRICH) Program | 001 | 5 | NIH | 3/12/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011811 | Eastern Nigeria Research Ethics Training (ENRICH) Program | 001 | 5 | NIH | 3/12/2025 | $150,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011804 | Strengthening Capacity in Health Research Ethics and Methodology in The Gambia | 000 | 4 | NIH | 3/12/2025 | $237,788 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH136968 | A circuit mechanism for the interactions between distinct learning systems | 000 | 2 | NIH | 3/12/2025 | $425,195 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 000 | 2 | NIH | 3/19/2025 | $36,338 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA292106 | Chemotherapy induced MASP activation and ovarian cancer metastasis | 000 | 1 | NIH | 1/30/2025 | $465,020 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS131223 | The role of NPRL2 loss in focal cortical dysplasia | 000 | 3 | NIH | 3/24/2025 | $347,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081436 | Defining lipid droplet homeostasis in Alzheimer's disease and aging with high molecular specificity using mass spectrometry imaging and isomer resolved lipidomics | 000 | 3 | NIH | 3/24/2025 | $496,317 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG073136 | Age-related decline in endogenous pain modulation and its impact on osteoarthritis pain | 000 | 4 | NIH | 3/7/2025 | $458,677 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI180181 | Innate immune receptor driven programmed necrosis is coupled to hyper-synthesis of inflammatory lipid mediators in host defense | 000 | 2 | NIH | 3/25/2025 | $194,375 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS119609 | Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms | 003 | 5 | NIH | 3/24/2025 | $375,952 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG076441 | Recovery among Older Adults Following Head Injury | 000 | 4 | NIH | 3/7/2025 | $600,915 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS122855 | Inflammatory changes and glymphatic dysfunction in carbon monoxide neuropathology | 000 | 4 | NIH | 3/24/2025 | $527,983 |
|
